Publications 2018

Adams P, Altes A, Brissot P, Butzeck B, Cabantchik I, Cancado R, Distante S, Evans P, Evans R, Ganz T, Girelli D, Hultcrantz R, McLaren G, Marris B, Milman N, Nemeth E, Nielsen P, Pineau B, Piperno A, Porto G, Prince D, Ryan J, Sanchez M, Santos P, Swinkels D et al. (2018)
Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
Hepatol. Int., 12 (2), 83-86
DOI 10.1007/s12072-018-9855-0

Skaarud KJ, Hjermstad MJ, Bye A, Veierod MB, Gudmundstuen AM, Lundin KEA, Distante S, Brinch L, Tjonnfjord GE, Iversen PO (2018)
Effects of individualized nutrition after allogeneic hematopoietic stem cell transplantation following myeloablative conditioning; a randomized controlled trial
Clin. Nutr. ESPEN, 28, 59-66
DOI 10.1016/j.clnesp.2018.08.002

Publications 2016

Distante S, Eikeland J, Pawar T, Skinnes R, Hoie K, You P, Morkrid L, Eide L (2016)
Blood removal therapy in hereditary hemochromatosis induces a stress response resulting in improved genome integrity
Transfusion, 56 (6), 1435-1441
DOI 10.1111/trf.13588

Publications 2015

Bolann BJ, Distante S, Morkrid L, Ulvik RJ (2015)
Bloodletting therapy in hemochromatosis: Does it affect trace element homeostasis?
J. Trace Elem. Med. Biol., 31, 225-229
DOI 10.1016/j.jtemb.2014.07.021

Publications 2012

Bolstad N, Kazaryan AM, Revheim ME, Distante S, Johnsrud K, Warren DJ, Nustad K, Edwin B (2012)
A Man with Abdominal Pain: Enough Evidence for Surgery?
Clin. Chem., 58 (8), 1187-1190
DOI 10.1373/clinchem.2011.167015

Publications 2006

Distante S (2006)
Genetic predisposition to iron overload: Prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation
Scand. J. Clin. Lab. Invest., 66 (2), 83-100
DOI 10.1080/00365510500495616

Publications 2004

Distante S, Robson KJH, Graham-Campbell J, Arnaiz-Villena A, Brissot P, Worwood M (2004)
The origin and spread of the HFE-C282Y haemochromatosis mutation
Hum. Genet., 115 (4), 269-279
DOI 10.1007/s00439-004-1152-4

Distante S, Robson KJH, Graham-Campbell J, Arnaiz-Villena A, Brissot P, Worwood M (2004)
The origin and spread of the HFE-C282Y haemochromatosis mutation
In Human genetics, Springer International, Berlin, 115(2004)4, S. 269-79
BIBSYS 05190831x

Publications 2003

Distante S (2003)
Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis associated HFE-C282Y gene mutation
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 134, 1 b. (flere pag.)
BIBSYS 040850374, ISBN 82-8080-066-2

Distante S, Elmberg M, Foss Haug KB, Øvstebø R, Berg JP, Kierulf P, Hultcrantz R, Bell H (2003)
Tumor necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemachromatosis
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 38(2003)8, s.871-7
BIBSYS 041707850

Distante S, Elmberg M, Haug KBF, Ovstebo R, Berg JP, Kierulf P, Hultcrantz R, Bell H (2003)
Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis
Scand. J. Gastroenterol., 38 (8), 871-877
DOI 10.1080/00365520310003444

Publications 2002

Distante S, Bjoro K, Hellum KB, Myrvang B, Berg JP, Skaug K, Raknerud N, Bell H (2002)
Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection
Liver, 22 (3), 269-275
DOI 10.1046/j.0106-9543.2002.01672.x

Distante S, Bjøro K, Hellum K, Myrvang B, Berg JP, Skaug K, Raknerud N, Bell H (2002)
Raised serum ferritin predicts non-response to interferonand ribavirin treatment in patients with chronic hepatitis C-infection
In Journal of hepatology, Munksgaard, København, 36(2002)Suppl 1, s. 233
BIBSYS 03142631x

Publications 2001

Distante S, Bell H (2001)
Phenotypic expression of the HFE gene mutation (C282Y) among the hospitalised population - Reply
Gut, 49 (1), 156

Publications 2000

Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E (2000)
The clinical expression of hemochromatosis in Oslo, Norway - Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects
Scand. J. Gastroenterol., 35 (12), 1301-1307

Bell H, Berg JP, Undlien DE, Distante S, Raknerud N, Heier HE, Try K, Thomassen Y, Haug E, Raha-Chowdhury R, Thorsby E (2000)
The clinical expression of hemachromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemachromatosis even in the HFE C282Y mutation negative subjects
In Scandinavian journal of gastroenterology, Taylor & Francis, Basingstoke, 35(2000)nr 12, s. 1301-1307
BIBSYS 010706097

Distante S, Berg JP, Lande K, Haug E, Bell H (2000)
HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis
Gut, 47 (4), 575-579
DOI 10.1136/gut.47.4.575

Distante S, Berg JP, Lande K, Haug E, Bell H (2000)
HFE gene mutation (C282Y) and phenotypic expression amonga hospitalised population in a high prevalence area of haemochromatosis
In Gut, British Medical Association, London, 47(2000)nr 4, s. 575-579
BIBSYS 010719873

Publications 1999

Distante S, Berg JP, Lande K, Haug E, Bell H (1999)
High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression
Scand. J. Gastroenterol., 34 (5), 529-534
DOI 10.1080/003655299750026290